Praluent, alirocumab
Named-patient access overview. Praluent is coordinated by Reserve Meds for international patients through cross-border sourcing coordinated with your treating doctor.
This page is informational, not medical advice.
Ask about Praluent
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
About Praluent
Praluent (alirocumab) is a fully human monoclonal antibody manufactured by Sanofi and Regeneron. It is a PCSK9 inhibitor, indicated as an adjunct to diet and maximally tolerated statin therapy in adults with primary hypercholesterolemia (including heterozygous familial hypercholesterolemia) and for the reduction of cardiovascular risk in adults with established cardiovascular disease. Praluent works by binding to PCSK9, a protein that regulates the recycling of LDL receptors on liver cells, increasing the liver's capacity to clear LDL cholesterol from the blood.
Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.
Praluent is administered as a subcutaneous injection, typically every two weeks or once monthly depending on the prescribed regimen. It is supplied in pre-filled pens or syringes and requires refrigerated handling between 2 and 8 degrees Celsius until use. Patients can briefly store the medicine at room temperature before injection, within the limits specified in the manufacturer's prescribing information.
For international patients whose home-country formulary either does not list Praluent, lists it with restrictive prior-authorization criteria, or imposes long waiting periods, US-sourced supply via a named-patient pathway is often the most direct route to consistent therapy.
Who Praluent is for
Praluent is generally considered for adults who have not reached their LDL-cholesterol goal on maximally tolerated statin therapy, those who are statin-intolerant, patients with heterozygous or homozygous familial hypercholesterolemia, and patients with established atherosclerotic cardiovascular disease who remain at high residual risk. The decision to initiate Praluent rests with the treating physician, who weighs lipid targets, cardiovascular risk profile, comorbid conditions, and prior therapy response.
How Reserve Meds coordinates Praluent
- Patient or treating physician submits a named-patient request through the Reserve Meds intake.
- Our clinical team reviews appropriateness of Praluent for the patient's lipid profile, cardiovascular history, and destination country.
- The treating physician issues a prescription and a brief clinical justification.
- Country-specific named-patient program or personal-import documentation is prepared.
- Praluent is sourced from a US-licensed pharmaceutical wholesale partner with full serial traceability from manufacturer to patient.
- Shipment is coordinated to the patient's physician, hospital pharmacy, or approved address, with refrigerated handling end-to-end.
Pricing and what shapes it
Praluent's total cost for international patients depends on the medicine, destination-country import duties and value-added tax, cold-chain logistics fees, and the Reserve Meds coordination fee. We do not publish a single global price because each of those layers shifts by country and by quantity dispensed. Once intake is complete and the destination is confirmed, our coordinator issues a firm quote in writing covering the full landed cost before any wire is requested.
Timing expectations
We give you a written timeline estimate for your case before you commit. The dominant variables are the speed at which the destination-country regulator processes named-patient paperwork, the patient's ability to provide a complete physician package, and cold-chain transit. Reserve Meds tracks each case through a single point of contact so the patient and physician always know what stage the case is in.
Clinical trials and expanded access
On 17 October 2026 we searched ClinicalTrials.gov, the clinical study registry of the US National Library of Medicine, for studies that list alirocumab as an intervention. The search found studies that are recruiting or not yet recruiting. See the current list on ClinicalTrials.gov.
Whether a patient can join a trial or an expanded access program is decided by the study team or the manufacturer, together with the treating doctor. Reserve Meds does not run trials or supply investigational medicines. We can help you and your doctor read a listing and understand the route.
Access by country
Reserve Meds publishes a detailed country deep-dive for Praluent in every market we coordinate. Each page below covers the destination-country regulatory pathway, how quotes work, indicative timelines, physician-credential requirements, and cold-chain handling. Tap any country to read the full deep-dive.
Cold-chain handling, in plain language
Praluent must remain refrigerated between 2 and 8 degrees Celsius from the wholesaler all the way to the patient's refrigerator. Reserve Meds uses validated thermal packaging with continuous temperature monitoring on every shipment. If a sensor records a temperature excursion in transit, the affected unit is quarantined and replaced; the patient is never asked to inject medication from a compromised package.
Documentation the physician will be asked to provide
The typical package includes a current prescription, a brief clinical justification letter, a copy of the physician's license, recent lipid-panel results, and the destination-country named-patient or personal-import form where applicable. Reserve Meds prepares the country-specific paperwork; the physician supplies the clinical pieces. We aim to keep the physician's workload to under thirty minutes per case.
Privacy and data handling
Patient information collected through Reserve Meds intake is handled under HIPAA standards in the United States and the privacy regimes that apply in the destination country, including UAE PDPL, KSA PDPL, India DPDPA, and the EU GDPR where relevant. We share only the minimum necessary information with the prescribing physician, the wholesaler, the carrier, and any regulator who requires submission.
Start a request for Praluent
Send us the medicine and your country. We reply within one business day with case-specific feasibility, timeline, and a formal quote.
Ask about a medicine Or message us on WhatsApp
Reserved for you.
Frequently asked questions
How can I get Praluent if it is not approved or available in my country?
Reserve Meds coordinates US-sourced Praluent for patients through a legal named-patient pathway, working with your treating doctor. Your treating physician provides the prescription and clinical justification; Reserve Meds prepares the named-patient documentation for your country and arranges DSCSA-compliant US sourcing and delivery to your physician or hospital pharmacy.
Can I access Praluent through a named-patient import?
Often, yes. Named-patient access (sometimes called personal import) is the legal route we use for FDA-approved medicines such as Praluent. It is different from compassionate use, which covers investigational medicines through the manufacturer's own program; we do not supply investigational medicines. Eligibility and paperwork depend on the regulator in your country, and Reserve Meds maps the specific pathway for each market it coordinates.
Do I need a prescription to access Praluent through Reserve Meds?
Yes. Reserve Meds is not a pharmacy and does not prescribe. A valid prescription and clinical justification from your treating physician are required, and all clinical decisions remain with your physician.
How does Reserve Meds deliver Praluent to a patient?
Medicines are supplied through a US-licensed pharmaceutical wholesale partner, and Reserve Meds coordinates delivery of Praluent to your treating physician or hospital pharmacy, with appropriate handling for the product.
How long does it take, and what does Praluent cost through Reserve Meds?
After a short intake, the clinical team responds within one business day with case-specific feasibility, an indicative timeline, and a formal written quote. Cost depends on the destination, the prescribed regimen, and the duration of therapy, and is confirmed in writing before anything proceeds.
How do I start a request for Praluent?
Submit a 60-second intake through the Reserve Meds patient portal, or message our team on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.